nonpharmaceutical intervention – Page 7 – Communicable Diseases Research

Community Behavioral and Perceived Responses in the COVID-19 Outbreak in Afghanistan: A Cross-Sectional Study

Original Research

Published on 2021-05-052022-10-31
Journal: Disaster Medicine and Public Health Preparedness [Category] COVID-19,

Upper Respiratory Infections in Schools and Childcare Centers Reopening after COVID-19 Dismissals, Hong Kong

Research Letter

Published on 2021-05-012022-10-31
Journal: Emerging Infectious Diseases [Category] COVID-19, MERS, SARS,

Returning to a Normal Life via COVID-19 Vaccines in the United States: A Large-scale Agent-Based Simulation Study

Original Paper

Published on 2021-04-292022-10-31
Journal: JMIR Medical Informatics [Category] COVID-19,

[키워드] accounted administration adopted age Agent-based agent-based model applied approval Capacity categories chose claimed cloud-based simulations Compliance Contact COVID-19 COVID-19 vaccines cumulative death drug effective Effectiveness Efficacy effort estimate Evidence experiment Factor food Government growth growth rate heterogeneity Immunity Impact individual Infection infections Interaction Intervention large-scale simulations life Logistic Lower Model Modification nonpharmaceutical intervention Nonpharmaceutical interventions normal objective operation outcome pandemic parameter parameters peer-reviewed study per day plan reduction in Result scenario Simulation speed Strategy the United State The United States the vaccine United States vaccination Vaccination strategy Vaccine virus were recorded Willingness
[DOI] 10.2196/27419 PMC 바로가기 [Article Type] Original Paper

Revisiting early-stage COVID-19 strategy options

Research Article

Published on 2021-04-232022-10-31
Journal: F1000Research [Category] COVID-19, MERS, SARS,

Estimating the effect of social inequalities on the mitigation of COVID-19 across communities in Santiago de Chile

칠레 산티아고의 지역 사회 전반에 걸쳐 COVID-19 완화에 대한 사회적 불평등의 영향 추정

Article

Published on 2021-04-232022-09-10
Journal: Nature Communications [Category] MERS, SARS, 치료기술,

Machine Learning–Based Prediction of Growth in Confirmed COVID-19 Infection Cases in 114 Countries Using Metrics of Nonpharmaceutical Interventions and Cultural Dimensions: Model Development and Validation

Original Paper

Published on 2021-04-232022-10-30
Journal: Journal of Medical Internet Research [Category] COVID-19, MERS, SARS,

Transmission of SARS-CoV-2 before and after symptom onset: impact of nonpharmaceutical interventions in China

Covid-19

Published on 2021-04-212022-10-31
Journal: European Journal of Epidemiology [Category] COVID-19, MERS, SARS,

Dynamic prioritization of COVID-19 vaccines when social distancing is limited for essential workers

403

Published on 2021-04-202022-10-29
Journal: Proceedings of the National Academy of Sciences of [Category] COVID-19, MERS,

[키워드] acute respiratory syndrome administration age approach Characteristics compartmental model Contact contribute coronavirus COVID-19 COVID-19 pandemic COVID-19 vaccine Critical death deaths disease dynamic Effectiveness epidemiological essential worker Essential workers Factors group groups heterogeneity Impact infections initial Intervention magnitude Mortality nonpharmaceutical intervention Older pandemic public health reduce SARS-CoV-2 severity Significance social distancing Sociodemographic Spread susceptibility the United State Transmission Transmission dynamics vaccination Vaccine vaccine prioritization viruses
[DOI] 10.1073/pnas.2025786118 PMC 바로가기 [Article Type] 403

The Uncounted Casualties of a Hidden COVID-19 Epidemic in China: Cross-sectional Study on Deaths Related to Overwork

Original Paper

Published on 2021-04-202022-10-30
Journal: Journal of Medical Internet Research [Category] COVID-19, MERS, SARS,

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

영국에서 SARS-CoV-2 계통 B.1.1.7의 추정 전파성 및 영향

Research Article

Published on 2021-04-092022-09-06
Journal: Science (New York, N.y.) [Category] Communicable Disease, MERS, SARS, 변종,

[키워드] 95% confidence interval absence accelerate accelerated acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age Alter appear approaches artifact B.1.1.7 B.1.1.7 variant baseline cause changes characterized Community competing complementary concern Contact coronavirus country COVID-19 COVID-19 case COVID-19 cases COVID-19 hospitalization dataset death deaths decrease Denmark disease severity dominant lineage educational institutions effective England estimate Estimated evaluated Evidence exhibit fixation generate genomic geographical area geographical areas greater help higher odd Hospital admissions hospitalizations human cells hypothese Impact incidence increase increase in increase in severity Infection infections inferences intervals lead Lineage Lineage B.1.1.7 major coronavirus mathematical mathematical model Mathematical models measure Measures median mitigate moderate multiple mechanism Mutation nonpharmaceutical intervention Nonpharmaceutical interventions occur Other outcomes positive predicted rationale Region Reproduction number respiratory robust SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 infections SARS-CoV-2 lineage SARS-CoV-2 variant Science Seven severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severity Severity of disease Sex social contact Spread spread to spreads statistical statistical analysis subpopulations Support Switzerland the epidemic The United States Transmissibility Transmission Transmission model transmission rate UK variant B.1.1.7 United Kingdom United States vaccination Vaccine variant variants variants of SARS-CoV-2 variety virus VoC VOC 202012/01
[DOI] 10.1126/science.abg3055 PMC 바로가기 [Article Type] Research Article